Navigation Links
Top Biopharma Company Adopts BioFortis' Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
Date:9/10/2008

COLUMBIA, Md., Sept. 10 /PRNewswire/ -- A top 5 bio-pharmaceutical company has licensed BioFortis' Labmatrix(TM) software for use enterprise-wide, across multiple therapeutic areas within its global Translational Medicine organization, BioFortis officials announced today. This large biopharmaceutical company decided to adopt the Labmatrix technology after an extensive review process that included a pilot by end users and the research informatics division. The company expects full implementation of Labmatrix to have a rapid and profound effect on the productivity of its Translational Medicine efforts.

"Labmatrix is the only data management and exploration application on the market that is built from the ground up to support translational medicine and biomarker discovery," said Jian Wang, BioFortis President and CEO. "There is a growing need in the biotechnology and pharmaceutical industry for robust informatics systems in the translational medicine space. This agreement demonstrates BioFortis' leadership position in fulfilling such needs," Dr. Wang concluded.

Labmatrix, an enterprise translational research information management software product, will be used to support Translational Medicine initiatives associated with research programs, clinical trials, and longitudinal clinical studies conducted with external collaborators.

About BioFortis

BioFortis is a privately-held company focused on providing biomedical research software and services to the life sciences sector, including government and academic research institutes and the biopharmaceutical industry. BioFortis' flagship product Labmatrix(TM) supports translational medicine initiatives with applications in clinical research, biobanking and biomarker discovery. Labmatrix enables transparent data management, integration, collaboration and compliance to privacy regulations.


'/>"/>
SOURCE BioFortis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. ARCA biopharma Appoints James Carr as Vice President of Marketing
10. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
11. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
Breaking Biology Technology:
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
Breaking Biology News(10 mins):